Joakim Wijkstrom News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Joakim wijkstrom. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Joakim Wijkstrom Today - Breaking & Trending Today

Insider Selling: Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) CMO Sells 3,724 Shares of Stock

Insider Selling: Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) CMO Sells 3,724 Shares of Stock
kopsource.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kopsource.com Daily Mail and Mail on Sunday newspapers.

Joakim Wijkstrom , Vanda Pharmaceuticals Trading Down , Envestnet Asset Management Inc , Yousif Capital Management , Summerhaven Investment Management , Quarter For Vanda Pharmaceuticals , Vanda Pharmaceuticals , News Ratings For Vanda Pharmaceuticals Daily , Vanda Pharmaceuticals Inc , Group Plc , Institutional Trading Of Vanda Pharmaceuticals , Get Free Report , Pharmaceuticals Trading Down , Asset Management , Capital Management , General Group Plc , Haven Investment Management , Pharmaceuticals Inc , Vanda Pharmaceuticals Daily ,

StockNews.com Initiates Coverage on Vanda Pharmaceuticals (NASDAQ:VNDA)

StockNews.com started coverage on shares of Vanda Pharmaceuticals (NASDAQ:VNDA – Get Rating) in a report released on Thursday morning. The brokerage issued a strong-buy rating on the biopharmaceutical company’s stock. Vanda Pharmaceuticals Trading Up 1.5 % NASDAQ VNDA opened at $6.20 on Thursday. The firm has a market cap of $356.13 million, a price-to-earnings ratio […] ....

United States , Mihael Hristos Polymeropoulos , Joakim Wijkstrom , News Ratings For Vanda Pharmaceuticals Daily , Vanda Pharmaceuticals , Vanda Pharmaceuticals Trading , America Corp , Allspring Global Investments Holdings , Vanda Pharmaceuticals Inc , Institutional Trading Of Vanda Pharmaceuticals , Insider Transactions At Vanda Pharmaceuticals , Millennium Management , Get Rating , Hristos Polymeropoulos , Street Corp , Asset Management , Global Investments Holdings , Vanda Pharmaceuticals Daily , Nasdaq Vnda , Initiated Coverage , Stocknews Com ,

Vanda Pharmaceuticals (NASDAQ:VNDA) Coverage Initiated by Analysts at StockNews.com

StockNews.com initiated coverage on shares of Vanda Pharmaceuticals (NASDAQ:VNDA – Get Rating) in a research note published on Thursday. The firm issued a strong-buy rating on the biopharmaceutical company’s stock. Vanda Pharmaceuticals Stock Down 1.6 % Shares of VNDA opened at $6.11 on Thursday. The company has a 50-day simple moving average of $6.53 and […] ....

Joakim Wijkstrom , Timothy Williams , Pricet Rowe Associates Inc , Vanda Pharmaceuticals Stock Down , Financial Services Group Inc , News Ratings For Vanda Pharmaceuticals Daily , Capital Advisors Ltd , Ghost Tree Capital , Hedge Funds Weigh In On Vanda Pharmaceuticals , Securities Exchange Commission , Vanda Pharmaceuticals , Vanda Pharmaceuticals Inc , Get Rating , Pharmaceuticals Stock Down , Exchange Commission , Services Group , Vanda Pharmaceuticals Daily , Nasdaq Vnda , Initiated Coverage , Stocknews Com ,

Capital Advisors Ltd. LLC Purchases New Stake in Vanda Pharmaceuticals Inc. (NASDAQ:VNDA)

Capital Advisors Ltd. LLC purchased a new stake in shares of Vanda Pharmaceuticals Inc. (NASDAQ:VNDA – Get Rating) in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor purchased 5,000 shares of the biopharmaceutical company’s stock, valued at approximately $37,000. Several other […] ....

Joakim Wijkstrom , Kevin Patrick Moran , Capital Advisors Ltd , Vanda Pharmaceuticals Inc , Securities Exchange Commission , News Ratings For Vanda Pharmaceuticals Daily , Legato Capital Management , Quarter For Vanda Pharmaceuticals , Vanda Pharmaceuticals Trading , Vanda Pharmaceuticals , Balyasny Asset Management , Capital Advisors , Get Rating , Asset Management , Exchange Commission , Patrick Moran , Vanda Pharmaceuticals Daily , Nasdaq Vnda , Sec Filings , Hedge Fund Holdings , Institutional Investor Holdings ,

KBC Group NV Lowers Stock Position in Vanda Pharmaceuticals Inc. (NASDAQ:VNDA)

KBC Group NV lessened its holdings in shares of Vanda Pharmaceuticals Inc. (NASDAQ:VNDA – Get Rating) by 49.6% during the 2nd quarter, Holdings Channel reports. The firm owned 5,483 shares of the biopharmaceutical company’s stock after selling 5,389 shares during the period. KBC Group NV’s holdings in Vanda Pharmaceuticals were worth $60,000 as of its […] ....

Joakim Wijkstrom , Vanda Pharmaceuticals Inc , Quarter For Vanda Pharmaceuticals , Kbc Group , Vanda Pharmaceuticals Stock Performance , Securities Exchange Commission , Vanda Pharmaceuticals , Insider Transactions At Vanda Pharmaceuticals , Nisa Investment Advisors , News Ratings For Vanda Pharmaceuticals Daily , Hsbc Holdings , Ci Investments Inc , Holdings Channel , Campbell Co Investment Adviser , Get Rating , Investment Advisors , Exchange Commission , Pharmaceuticals Inc , Visit Holdingschannel , Vanda Pharmaceuticals Daily , Nasdaq Vnda , Sec Filings , Hedge Fund Holdings , Institutional Investor Holdings ,